Cytosorbents (CTSO) Gross Margin Growth (1y) (2012 - 2026)
Cytosorbents (CTSO) Gross Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 128.00 |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 448.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 60.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 305.00 |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -6.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 391.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 153.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -4,158.00 |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 69.00 |
| 10 | Cytosorbents | 21.98 Mn | 17.56 Mn | 7.05 Mn | 232.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 232.00 |
| Mar 31, 2026 | -197.00 |
| Dec 31, 2025 | 533.00 |
| Sep 30, 2025 | 926.00 |
| Jun 30, 2025 | -269.00 |
| Mar 31, 2025 | -534.00 |
| Dec 31, 2024 | 708.00 |
| Sep 30, 2024 | -261.00 |
| Jun 30, 2024 | 966.00 |
| Mar 31, 2024 | 1,873.00 |
| Dec 31, 2023 | -3.00 |
| Sep 30, 2023 | 1,904.00 |
| Jun 30, 2023 | 568.00 |
| Mar 31, 2023 | -1,606.00 |
| Dec 31, 2022 | -973.00 |
| Sep 30, 2022 | -3,017.00 |
| Jun 30, 2022 | -1,925.00 |
| Mar 31, 2022 | -25.00 |
| Dec 31, 2021 | -782.00 |
| Sep 30, 2021 | 217.00 |